18
Participants
Start Date
November 30, 2011
Primary Completion Date
October 31, 2014
Study Completion Date
October 31, 2014
Antithrombin III
Patients randomized to receive Antithrombin concentrate will receive a dose of AT to achieve a target value of 1.2U/ml.
Saline Placebo
Patients randomized to the control group will receive a placebo consisting of normal saline in a volume equivalent to the volume of antithrombin the same patient in the treatment group would have received and administered by anesthesia and perfusion in the exact same manner as the AT is administered in the treatment group.
The Hospital for Sick Children, Toronto
The Hospital for Sick Children
OTHER